Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Coronavirus: a clinical update of Covid-19
Mateus da Silveira Cespedes1, José Carlos Rosa Pires de Souza2
1. Acadêmico de medicina da Universidade Estadual de Mato Grosso do Sul, Dourados, MS, Brasil.
Insights
The COVID-19 pandemic, caused by SARS-CoV-2, presents mild to severe symptoms and spreads similarly to H1N1 but with lower mortality. Early detection and supportive care are key, with potential treatments like hydroxychloroquine and azithromycin for severe cases.
Area of Science:
- Virology
- Epidemiology
- Infectious Diseases
Background:
- The COVID-19 pandemic, declared by the WHO, has increased global awareness of the SARS-CoV-2 virus.
- The virus affects individuals with comorbidities and advanced age, with transmissibility similar to H1N1 but lower mortality rates.
- SARS-CoV-2 invades cells via angiotensin-converting enzyme 2, affecting the respiratory and intestinal mucosa.
Purpose of the Study:
- To summarize the key aspects of the COVID-19 pandemic, including its epidemiology, viral characteristics, clinical presentation, and management strategies.
- To highlight the diagnostic capabilities and potential therapeutic interventions for COVID-19.
Main Methods:
- Review of epidemiological data on COVID-19 spread and transmissibility.
- Description of the SARS-CoV-2 virus's cellular invasion mechanism.
- Categorization of clinical presentations into mild and severe forms.
- Discussion of diagnostic methods like CRP-TR for viral load detection.
- Overview of supportive care, infection control, and potential pharmacological treatments.
Main Results:
- COVID-19 has spread globally, affecting a significant number of patients.
- Clinical presentation ranges from mild symptoms (fever, cough) to severe respiratory distress (hypoxemia, dyspnea).
- A 2% mortality rate is estimated, with supportive care and infection control as primary management.
Conclusions:
- Early detection of viral load using CRP-TR is crucial for patients with high clinical suspicion.
- Supportive measures and infection control are the cornerstones of COVID-19 management.
- While hydroxychloroquine and azithromycin show promise for severe cases, corticosteroids should be avoided. ACEIs/ARBs use is unrestricted.
Abstract:
A covid-19 pandemic decreed by WHO has raised greater awareness of it. The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. A presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%.allows the detection of viral load in CRP-TR of patients with high clinical suspicion. Based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and ACEIs / ARBs.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Single Nucleotide Polymorphisms-SNPs
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology